We further showed that PRDX2 is functionally required for CD133+CD44+ CCSC stemness maintenance, tumor initiation, migration and invasion, and liver metastasis, and the expression of various EMT markers and Wnt/β-catenin signaling proteins was altered after PRDX2 inhibition. The gene discussed is PRDX2; the disease is neoplasm.